The Johns Hopkins University School Of Medicine

University Of Michigan Medical School

University Of Michigan

Greater New York City Area

Memorial Sloan Kettering Cancer Center

Head, Division of Solid Tumor Oncology

Jounce Therapeutics, Inc.

Director

PGDx was formed in 2010 by to commercialize tumor tissue and liquid based cancer genomic sequencing for physicians, researchers and pharma partners.  From 2010-2016, PGDx grew  organically from one to over sixty employees with an emphasis on computational biology, research & development and genomic sciences.  In 2014, PGDx took in $2.8MM of angel funding followed by a $21.4MM round of institutional funding from the elite venture capitalists, New Enterprise Associates.  During their tenure leading PGDx, Diaz and Velculescu, created a profitable business that offers a suite of the most advanced genomic tests in the diagnostics marketplace.  PGDx is now primed for rapid growth and is actively recruiting an executive team.  Most recently, founder's Diaz and Velculescu were awarded the Ernst & Young Entrepreneur of the Year Award for the Maryland Region. <a href="http://www.pgdx.com/">http://www.pgdx.com/</a>

Personal Genome Diagnostics

Chairman Of The Board and co-Founder

Founder of clinical messaging company that provides services to Johns Hopkins, UCSF, and multiple other hospitals. Transformed the practice of medicine by streamlining communications for physicians, nurses, administrators, and the interdisciplinary team. Over 4 million visits per month with continuous operations for over 20 years.

Pagerbox

Co-Founder

Luis Diaz